Short answer
Benitec Biopharma Inc. (BNTC) filed an 8-K current report with the SEC on September 30, 2026 reporting Item 4.01 (Changes in Registrant's Certifying Accountant). Ernst & Young LLP appointed independent registered public accounting firm for fiscal year ending June 30, 2027.
- This filing includes Item 4.01, an item that often signal trouble.
Benitec Biopharma Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 4.01 · Changes in Registrant's Certifying Accountant
- Ernst & Young LLP appointed independent registered public accounting firm for fiscal year ending June 30, 2027
- EY completed client acceptance procedures on September 28, 2026
- Engagement letter executed September 29, 2026, formalizing the auditor transition
- Auditor change requires investor attention for oversight continuity and potential reporting-process implications
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Benitec Biopharma Inc. 8-K filings
Get the next BNTC 8-K as it lands
Follow BNTC for push alerts, or ask the research agent what this filing means.